Achieving Regulatory Readiness for New Bio-Pharma Plants
The high-stakes world of biopharmaceuticals, the distance between a state-of-the-art facility and a multi-million dollar Warning Letter is thinner than a sterile filter. As we navigate the regulatory landscape of 2026, the mantra has shifted from passing the inspection to a sustained state of control. Whether you are breaking ground on a greenfield site or […]
